Adverse Events Clinical Trial
Official title:
An Independent Review of Safety Data From a Closed Clinical Study Using Irrisept (Protocol IRR-CT-901-2013-01)
The purpose of CLP-01 was to complete the safety endpoint of the closed trial and ensure that all safety data generated by IRR-CT-901-2013-01 was accounted for and accurately identified, verified, and independently adjudicated. CLP-01 does not include an evaluation of the efficacy or exploratory endpoints from IRR-CT-901-2013-01. CLP-01 did not enroll new subjects and relied solely on data collected in the subject source and medical records in IRR-CT-901-2013-01. CLP-01 was conducted between March 2020 and November 2021.
Between 2013 and 2016, Irrimax Corporation sponsored a prospective clinical study (IRR-CT-901-2013-01; NCT02255487) in the United States under IRB approval. IRR-CT-901-2013-01 defined primary and secondary efficacy, exploratory, and safety endpoints. The safety endpoint from IRR-CT-901-2013-01 was a clinical review and analysis of Adverse Events (AEs). However, IRR-CT-901-2013-01 was terminated early after the Interim Analysis primarily because of issues with the accuracy and completeness of the data collected for IRR-CT-901-2013-01, the lack of SoC standardization, and challenges assessing study endpoints arising out of the complexity of the trauma and co-morbidities of the subjects enrolled. The sole purpose of CLP-01 was to complete the safety endpoint for IRR-CT-901-2013-01. CLP-01 reviewed all AEs recorded in IRR-CT-901-2013-01 and identified additional AEs in the subject source and medical records. All AEs were assessed for severity and causality and were reviewed by the individual Principal Investigators (PIs) at each site and the CLP-01 Medical Monitor (MM). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05390125 -
Effectiveness of a Proficiency-based Progression Communication Training Programme
|
||
Completed |
NCT04012320 -
Efficacy and Safety on the Use of Bisphosphonates in Paediatrics
|
||
Completed |
NCT02268331 -
Comparison of Active vs. Passive Surveillance to Collect Adverse Events
|
N/A | |
Completed |
NCT00244673 -
Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination
|
Phase 4 | |
Recruiting |
NCT05038527 -
ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery
|
N/A | |
Completed |
NCT01291667 -
Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE
|
Phase 3 | |
Completed |
NCT00681395 -
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium
|
Phase 1 | |
Recruiting |
NCT05311579 -
Niraparib Plus Anlotinib for Recurrent Ovarian Cancer
|
Phase 2 | |
Recruiting |
NCT05310344 -
Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer
|
Phase 2 | |
Recruiting |
NCT05311566 -
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
|
Phase 2 | |
Completed |
NCT05815615 -
Plasmapheresis: a Multi-modal Approach
|
N/A | |
Completed |
NCT02130570 -
Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions
|
N/A | |
Recruiting |
NCT05804188 -
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
|
||
Not yet recruiting |
NCT06117176 -
Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III
|
||
Recruiting |
NCT02725073 -
Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma
|
Phase 2 | |
Completed |
NCT02928705 -
Quality of Telemedically Guided Prehospital Analgesia
|
N/A | |
Terminated |
NCT02011607 -
Incidence of Adverse Airway Events in High Risk Patients Undergoing Upper GI Endoscopy Under Anesthesia
|
||
Withdrawn |
NCT01128127 -
Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)
|
N/A | |
Completed |
NCT02310815 -
ReSure Sealant Post Approval Study
|
N/A | |
Recruiting |
NCT05709392 -
Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS
|
N/A |